Contribution of mycophenolate mofetil after withdrawal of cyclosporine to toxicity in kidney transplantation

被引：2
|
作者：
Hazzan, M [1 ]
Bourdon, F [1 ]
Dracon, M [1 ]
Lelièvre, G [1 ]
Noël, C [1 ]
机构：
[1] CHUR Lille, Hop Calmette, Serv Nephrol A, F-59037 Lille, France
来源：
TRANSPLANTATION PROCEEDINGS | 1998年 / 30卷 / 06期
关键词：
D O I：
10.1016/S0041-1345(98)00819-7
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：2809 / 2810
页数：2
相关论文
共 50 条
  • [1] EARLY CYCLOSPORINE WITHDRAWAL WITH MYCOPHENOLATE MOFETIL AFTER KIDNEY TRANSPLANTATION: TEN YEARS AFTER
    Tabibzadeh, N.
    Provot, F.
    Elsermans, V.
    Glowacki, F.
    Lionet, A.
    Gnemmi, V.
    Noel, C.
    Hazzan, M.
    TRANSPLANT INTERNATIONAL, 2015, 28 : 17 - 18
  • [2] Steroid withdrawal and reduction of cyclosporine A under mycophenolate mofetil after heart transplantation
    Faulhaber, Marion
    Maeding, Ilona
    Malehsa, Doris
    Raggi, Matthias C.
    Haverich, Axel
    Bara, Christoph L.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2013, 15 (04) : 712 - 717
  • [3] Comparative trial of Prograf (tacrolimus) in combination with azathioprine or mycophenolate mofetil vs. neoral (cyclosporine) with mycophenolate mofetil after kidney transplantation
    Gonwa, T
    Ahsan, N
    Halloran, P
    Stegall, M
    Hardy, M
    Metzger, R
    Shield, C
    Rocher, L
    Scandling, J
    Sorense, J
    Mulloy, L
    Light, J
    Corwin, C
    Danovitch, G
    Wachs, M
    Van Veldhuisen, P
    Salm, K
    Tolzman, D
    Fitzsimmons, W
    TRANSPLANTATION, 1999, 67 (07) : S239 - S239
  • [4] Prednisolone withdrawal after pancreas-kidney transplantation in patients treated with Tacrolimus and Mycophenolate Mofetil
    Kani, A
    Lorenz, F
    Pohle, C
    Bechstein, WO
    Platz, K
    Neuhaus, P
    Frei, U
    TRANSPLANTATION, 1999, 67 (07) : S223 - S223
  • [5] Mycophenolate mofetil in the prevention of rejection after kidney transplantation
    Kiehl, MG
    TRANSPLANTATION, 2000, 69 (08) : 1753 - 1753
  • [6] Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil - A prospective randomized study
    Ahsan, N
    Hricik, D
    Matas, A
    Rose, S
    Tomlanovich, S
    Wilkinson, A
    Ewell, M
    McIntosh, M
    Stablein, D
    Hodge, E
    Hayes, D
    Gores, P
    Cohen, D
    Gonwa, T
    Brinler, K
    Harland, R
    Neylan, J
    Pescovitz, M
    Wynn, J
    Ahsan, N
    Yang, HC
    Bennett, W
    Copley, J
    Wilkinson, A
    Dunn, J
    Tomlanovich, S
    Chan, L
    Bertolatus, JA
    Weir, M
    Mendez, R
    Pirsch, J
    Helderman, JH
    TRANSPLANTATION, 1999, 68 (12) : 1865 - 1874
  • [7] Prospective, randomized trial of steroid withdrawal in kidney recipients treated with mycophenolate mofetil and cyclosporine
    Pelletier, RP
    Akin, B
    Ferguson, RM
    CLINICAL TRANSPLANTATION, 2006, 20 (01) : 10 - 18
  • [8] Successful steroid withdrawal during the first year after renal transplantation in mycophenolate mofetil and Cyclosporine treated patients
    Budde, K
    Hallebach, G
    Geissler, S
    Fritsche, L
    Waiser, J
    Bauer, S
    Mai, I
    Giessing, M
    Türk, I
    Neumayer, HH
    TRANSPLANTATION, 1999, 67 (07) : S160 - S160
  • [9] Elective withdrawal of mycophenolate mofetil in renal transplant recipients treated with mycophenolate mofetil, cyclosporine, and prednisone
    ter Meulen, CG
    Gregoor, PJHS
    Weimar, W
    Hilbrands, LB
    TRANSPLANT INTERNATIONAL, 2001, 14 (02) : 99 - 102
  • [10] Comparison of the safety and efficacy of mycophenolate mofetil, prednisolone and cyclosporine and conventional cyclosporine and prednisolone in kidney transplantation
    Kim, HC
    Park, SB
    Kim, HT
    Cho, WH
    Park, CH
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 1751 - 1752
12345